AZ pulls back on Inovio immuno-oncology pact
AstraZeneca (AZ) and MedImmune, have announced that the latest trial of Fasenra (benralizumab) in patients with moderate-to-very-severe chronic obstructive pulmonary disease (COPD) did not provide a statistically-significant reduction in exacerbations.
AstraZeneca’s Bahija Jallal was named the Healthcare Businesswomen’s Association (HBA) Women of the Year for 2017 – in what turned out to a watershed year for women’s rights.
Start ups and entrepreneurs in the UK who have developed or are looking to create a digital healthcare solution are being invited to submit entries to a new prize fund organised by Medimmune.
Launch of Injectable Drug Delivery
Company takes $80m hit.